Inozyme Pharma, Inc. (INZY) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts INZY Hot Sheet
Join SI Premium – FREE
Inozyme Pharma, Inc. (NASDAQ: INZY) reported Q1 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Inozyme Pharma, Inc. (INZY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Stripe, Advent In Talks To Buy Paypal - WSJ
- AI/ML Innovations plans $2M private placement on the CSE
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
